Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine vs Premixed Insulin in Type 2 Diabetes Failing Oral Agents
NCT01121835Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2010
- Primary completion
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 16
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Feb 2010; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01121835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121835.